PCM
JNCE

PenderFund Capital Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

PenderFund Capital Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-246,310
Closed -$616K – 150
2023
Q1 		$616K Buy
+246,310
New +$616K 0.19% 82